Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural and Physiological Correlates of Psychedelic Sub-states (i2)
NCT05698511Phase 1Active, not recruiting
- Start
- Jul 2023
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of psilocybin. Primary endpoint: Brain-averaged normalized global signal complexity. Started Jul 2023; status: active, not recruiting.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT05698511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05698511.